Clinical Trials Browser

Phase 3 × OTHER × lanreotide × Clear all

NCT06878664 2025-09-02

RIALTO

Phase 3 Recruiting

Neuroendocrine Tumors

NCT03439709 2018-03-01

MERGE

Phase 3 Unknown

Acromegaly, Pituitary Neoplasms, Growth Hormone-Secreting Pituitary Adenoma